Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Acute Toxicity and Early Oncological Outcomes After Intraoperative Electron Radiotherapy (IOERT) as Boost Followed by Whole Breast Irradiation in 157 Early Stage Breast Cancer Patients-First Clinical Results From a Single Center.

König L, Lang K, Heil J, Golatta M, Major G, Krug D, Hörner-Rieber J, Häfner MF, Koerber SA, Harrabi S, Bostel T, Debus J, Uhl M.

Front Oncol. 2019 May 21;9:384. doi: 10.3389/fonc.2019.00384. eCollection 2019.

2.

Assembling the brain trust: the multidisciplinary imperative in neuro-oncology.

Ludmir EB, Mahajan A, Ahern V, Ajithkumar T, Alapetite C, Bernier-Chastagner V, Bindra RS, Bishop AJ, Bolle S, Brown PD, Carrie C, Chalmers AJ, Chang EL, Chung C, Dieckmann K, Esiashvili N, Gandola L, Ghia AJ, Gondi V, Grosshans DR, Harrabi SB, Horan G, Indelicato DJ, Jalali R, Janssens GO, Krause M, Laack NN, Laperriere N, Laprie A, Li J, Marcus KJ, McGovern SL, Merchant TE, Merrell KW, Padovani L, Parkes J, Paulino AC, Schwarz R, Shih HA, Souhami L, Sulman EP, Taylor RE, Thorp N, Timmermann B, Wheeler G, Wolden SL, Woodhouse KD, Yeboa DN, Yock TI, Kortmann RD, McAleer MF.

Nat Rev Clin Oncol. 2019 May 31. doi: 10.1038/s41571-019-0235-z. [Epub ahead of print] No abstract available.

PMID:
31150024
3.

Clinical Management of Blood⁻Brain Barrier Disruptions after Active Raster-Scanned Carbon Ion Re-Radiotherapy in Patients with Recurrent Head-and-Neck Cancer.

Held T, Akbaba S, Lang K, Harrabi S, Bernhardt D, Freudlsperger C, Kargus S, Plinkert P, Rieken S, Herfarth K, Debus J, Adeberg S.

Cancers (Basel). 2019 Mar 19;11(3). pii: E383. doi: 10.3390/cancers11030383.

4.

Dosimetric Comparison of Proton Radiation Therapy, Volumetric Modulated Arc Therapy, and Three-Dimensional Conformal Radiotherapy Based on Intracranial Tumor Location.

Adeberg S, Harrabi SB, Bougatf N, Verma V, Windisch P, Bernhardt D, Combs SE, Herfarth K, Debus J, Rieken S.

Cancers (Basel). 2018 Oct 26;10(11). pii: E401. doi: 10.3390/cancers10110401.

5.

High-resolution FLAIR MRI at 7 Tesla for treatment planning in glioblastoma patients.

Regnery S, Knowles BR, Paech D, Behl N, Meissner JE, Windisch P, Ben Harrabi S, Bernhardt D, Schlemmer HP, Ladd ME, Rieken S, Debus J, Adeberg S.

Radiother Oncol. 2019 Jan;130:180-184. doi: 10.1016/j.radonc.2018.08.002. Epub 2018 Aug 31.

6.

Metformin Enhanced in Vitro Radiosensitivity Associates with G2/M Cell Cycle Arrest and Elevated Adenosine-5'-monophosphate-activated Protein Kinase Levels in Glioblastoma.

Adeberg S, Bernhardt D, Harrabi SB, Nicolay NH, Hörner-Rieber J, König L, Repka M, Mohr A, Abdollahi A, Weber KJ, Debus J, Rieken S.

Radiol Oncol. 2017 Nov 1;51(4):431-437. doi: 10.1515/raon-2017-0042. eCollection 2017 Dec.

7.

Treatment of meningioma and glioma with protons and carbon ions.

Adeberg S, Harrabi SB, Verma V, Bernhardt D, Grau N, Debus J, Rieken S.

Radiat Oncol. 2017 Dec 1;12(1):193. doi: 10.1186/s13014-017-0924-7. Review.

8.

Sequential proton boost after standard chemoradiation for high-grade glioma.

Adeberg S, Bernhardt D, Harrabi SB, Uhl M, Paul A, Bougatf N, Verma V, Unterberg A, Wick W, Haberer T, Combs SE, Herfarth K, Debus J, Rieken S.

Radiother Oncol. 2017 Nov;125(2):266-272. doi: 10.1016/j.radonc.2017.09.040. Epub 2017 Oct 16.

PMID:
29050959
9.

Malignant pleural mesothelioma - Pleural cavity irradiation after decortication with helical tomotherapy.

Harrabi SB, Koerber SA, Adeberg S, Katayama S, Herfarth K, Debus J, Sterzing F.

Rep Pract Oncol Radiother. 2017 Sep-Oct;22(5):402-407. doi: 10.1016/j.rpor.2017.07.006. Epub 2017 Aug 11.

10.

Do Increased Doses to Stem-Cell Niches during Radiation Therapy Improve Glioblastoma Survival?

Adeberg S, Harrabi SB, Bougatf N, Bernhardt D, Mohr A, Rieber J, Koelsche C, Rieken S, Debus J.

Stem Cells Int. 2016;2016:8793462. doi: 10.1155/2016/8793462. Epub 2016 Jun 27.

11.

Radiotherapy plus concomitant temozolomide in primary gliosarcoma.

Adeberg S, Bernhardt D, Harrabi SB, Diehl C, Koelsche C, Rieken S, Unterberg A, von Deimling A, Debus J.

J Neurooncol. 2016 Jun;128(2):341-8. doi: 10.1007/s11060-016-2117-x. Epub 2016 Mar 30.

PMID:
27025857
12.

S-phase-specific radiosensitization by gemcitabine for therapeutic carbon ion exposure in vitro.

Harrabi SB, Adeberg S, Winter M, Haberer T, Debus J, Weber KJ.

J Radiat Res. 2016 Mar;57(2):110-4. doi: 10.1093/jrr/rrv097. Epub 2016 Jan 7.

13.

Metformin influences progression in diabetic glioblastoma patients.

Adeberg S, Bernhardt D, Ben Harrabi S, Bostel T, Mohr A, Koelsche C, Diehl C, Rieken S, Debus J.

Strahlenther Onkol. 2015 Dec;191(12):928-35. doi: 10.1007/s00066-015-0884-5. Epub 2015 Sep 2.

PMID:
26329695
14.

Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma.

Adeberg S, Bostel T, Harrabi S, Bernhardt D, Welzel T, Wick W, Debus J, Combs SE.

BMC Cancer. 2015 Jul 30;15:558. doi: 10.1186/s12885-015-1545-x.

15.

Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects.

Harrabi SB, Adeberg S, Welzel T, Rieken S, Habermehl D, Debus J, Combs SE.

Radiat Oncol. 2014 Sep 16;9:203. doi: 10.1186/1748-717X-9-203.

16.

Glioblastoma recurrence patterns after radiation therapy with regard to the subventricular zone.

Adeberg S, König L, Bostel T, Harrabi S, Welzel T, Debus J, Combs SE.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):886-93. doi: 10.1016/j.ijrobp.2014.07.027. Epub 2014 Sep 11.

PMID:
25220720
17.

Temozolomide in combination with carbon ion or photon irradiation in glioblastoma multiforme cell lines - does scheduling matter?

Harrabi S, Combs SE, Brons S, Haberer T, Debus J, Weber KJ.

Int J Radiat Biol. 2013 Sep;89(9):692-7. doi: 10.3109/09553002.2013.791406. Epub 2013 May 13.

PMID:
23577964

Supplemental Content

Loading ...
Support Center